Global Laboratory-developed Testing Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that 'home brew' tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
According to APO Research, The global Laboratory-developed Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.
North America is the largest market with more than 65% of the market, followed by Europe with about 15%.
This report presents an overview of global market for Laboratory-developed Testing, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Laboratory-developed Testing, also provides the value of main regions and countries. Of the upcoming market potential for Laboratory-developed Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Laboratory-developed Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Laboratory-developed Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Descriptive company profiles of the major global players, including Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics and Adaptive Biotechnologies, etc.
Laboratory-developed Testing segment by Company
1. To analyze and research the global Laboratory-developed Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Laboratory-developed Testing key companies, revenue, market share, and recent developments.
3. To split the Laboratory-developed Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Laboratory-developed Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Laboratory-developed Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Laboratory-developed Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory-developed Testing industry.
Chapter 3: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Laboratory-developed Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Laboratory-developed Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Chapter 9: Concluding Insights.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
According to APO Research, The global Laboratory-developed Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.
North America is the largest market with more than 65% of the market, followed by Europe with about 15%.
This report presents an overview of global market for Laboratory-developed Testing, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Laboratory-developed Testing, also provides the value of main regions and countries. Of the upcoming market potential for Laboratory-developed Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Laboratory-developed Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Laboratory-developed Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Descriptive company profiles of the major global players, including Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics and Adaptive Biotechnologies, etc.
Laboratory-developed Testing segment by Company
- Adaptive Biotechnologies Corporation
- Quest Diagnostics
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Biotheranostics
- Adaptive Biotechnologies
- Rosetta Genomics
- Biodesix
- Helix
- Commercial Service
- R&D
- Genetic Testing
- Oncology
- Infectious Disease
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Laboratory-developed Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Laboratory-developed Testing key companies, revenue, market share, and recent developments.
3. To split the Laboratory-developed Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Laboratory-developed Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Laboratory-developed Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Laboratory-developed Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory-developed Testing industry.
Chapter 3: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Laboratory-developed Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Laboratory-developed Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Laboratory-developed Testing Market Size, 2019 VS 2023 VS 2030
1.3 Global Laboratory-developed Testing Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 LABORATORY-DEVELOPED TESTING MARKET DYNAMICS
2.1 Laboratory-developed Testing Industry Trends
2.2 Laboratory-developed Testing Industry Drivers
2.3 Laboratory-developed Testing Industry Opportunities and Challenges
2.4 Laboratory-developed Testing Industry Restraints
3 LABORATORY-DEVELOPED TESTING MARKET BY COMPANY
3.1 Global Laboratory-developed Testing Company Revenue Ranking in 2023
3.2 Global Laboratory-developed Testing Revenue by Company (2019-2024)
3.3 Global Laboratory-developed Testing Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Laboratory-developed Testing Company Manufacturing Base & Headquarters
3.5 Global Laboratory-developed Testing Company, Product Type & Application
3.6 Global Laboratory-developed Testing Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Laboratory-developed Testing Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Laboratory-developed Testing Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 LABORATORY-DEVELOPED TESTING MARKET BY TYPE
4.1 Laboratory-developed Testing Type Introduction
4.1.1 Commercial Service
4.1.2 R&D
4.2 Global Laboratory-developed Testing Sales Value by Type
4.2.1 Global Laboratory-developed Testing Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Laboratory-developed Testing Sales Value by Type (2019-2030)
4.2.3 Global Laboratory-developed Testing Sales Value Share by Type (2019-2030)
5 LABORATORY-DEVELOPED TESTING MARKET BY APPLICATION
5.1 Laboratory-developed Testing Application Introduction
5.1.1 Genetic Testing
5.1.2 Oncology
5.1.3 Infectious Disease
5.1.4 Others
5.2 Global Laboratory-developed Testing Sales Value by Application
5.2.1 Global Laboratory-developed Testing Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Laboratory-developed Testing Sales Value by Application (2019-2030)
5.2.3 Global Laboratory-developed Testing Sales Value Share by Application (2019-2030)
6 LABORATORY-DEVELOPED TESTING MARKET BY REGION
6.1 Global Laboratory-developed Testing Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Laboratory-developed Testing Sales Value by Region (2019-2030)
6.2.1 Global Laboratory-developed Testing Sales Value by Region: 2019-2024
6.2.2 Global Laboratory-developed Testing Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Laboratory-developed Testing Sales Value (2019-2030)
6.3.2 North America Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Laboratory-developed Testing Sales Value (2019-2030)
6.4.2 Europe Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Laboratory-developed Testing Sales Value (2019-2030)
6.5.2 Asia-Pacific Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Laboratory-developed Testing Sales Value (2019-2030)
6.6.2 Latin America Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Laboratory-developed Testing Sales Value (2019-2030)
6.7.2 Middle East & Africa Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
7 LABORATORY-DEVELOPED TESTING MARKET BY COUNTRY
7.1 Global Laboratory-developed Testing Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Laboratory-developed Testing Sales Value by Country (2019-2030)
7.2.1 Global Laboratory-developed Testing Sales Value by Country (2019-2024)
7.2.2 Global Laboratory-developed Testing Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.3.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.4.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.5.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.6.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.7.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.8.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.9.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.10.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.11.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.12.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.13.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.14.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.15.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.16.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.17.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.18.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.19.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.20.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.21.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Adaptive Biotechnologies Corporation
8.1.1 Adaptive Biotechnologies Corporation Comapny Information
8.1.2 Adaptive Biotechnologies Corporation Business Overview
8.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio
8.1.5 Adaptive Biotechnologies Corporation Recent Developments
8.2 Quest Diagnostics
8.2.1 Quest Diagnostics Comapny Information
8.2.2 Quest Diagnostics Business Overview
8.2.3 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.2.4 Quest Diagnostics Laboratory-developed Testing Product Portfolio
8.2.5 Quest Diagnostics Recent Developments
8.3 Roche
8.3.1 Roche Comapny Information
8.3.2 Roche Business Overview
8.3.3 Roche Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.3.4 Roche Laboratory-developed Testing Product Portfolio
8.3.5 Roche Recent Developments
8.4 Illumina
8.4.1 Illumina Comapny Information
8.4.2 Illumina Business Overview
8.4.3 Illumina Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.4.4 Illumina Laboratory-developed Testing Product Portfolio
8.4.5 Illumina Recent Developments
8.5 Qiagen
8.5.1 Qiagen Comapny Information
8.5.2 Qiagen Business Overview
8.5.3 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.5.4 Qiagen Laboratory-developed Testing Product Portfolio
8.5.5 Qiagen Recent Developments
8.6 Eurofins
8.6.1 Eurofins Comapny Information
8.6.2 Eurofins Business Overview
8.6.3 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.6.4 Eurofins Laboratory-developed Testing Product Portfolio
8.6.5 Eurofins Recent Developments
8.7 Guardant Health
8.7.1 Guardant Health Comapny Information
8.7.2 Guardant Health Business Overview
8.7.3 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.7.4 Guardant Health Laboratory-developed Testing Product Portfolio
8.7.5 Guardant Health Recent Developments
8.8 Biotheranostics
8.8.1 Biotheranostics Comapny Information
8.8.2 Biotheranostics Business Overview
8.8.3 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.8.4 Biotheranostics Laboratory-developed Testing Product Portfolio
8.8.5 Biotheranostics Recent Developments
8.9 Adaptive Biotechnologies
8.9.1 Adaptive Biotechnologies Comapny Information
8.9.2 Adaptive Biotechnologies Business Overview
8.9.3 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.9.4 Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio
8.9.5 Adaptive Biotechnologies Recent Developments
8.10 Rosetta Genomics
8.10.1 Rosetta Genomics Comapny Information
8.10.2 Rosetta Genomics Business Overview
8.10.3 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.10.4 Rosetta Genomics Laboratory-developed Testing Product Portfolio
8.10.5 Rosetta Genomics Recent Developments
8.11 Biodesix
8.11.1 Biodesix Comapny Information
8.11.2 Biodesix Business Overview
8.11.3 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.11.4 Biodesix Laboratory-developed Testing Product Portfolio
8.11.5 Biodesix Recent Developments
8.12 Helix
8.12.1 Helix Comapny Information
8.12.2 Helix Business Overview
8.12.3 Helix Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.12.4 Helix Laboratory-developed Testing Product Portfolio
8.12.5 Helix Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
10.6 Disclaimer
1.1 Product Definition
1.2 Global Laboratory-developed Testing Market Size, 2019 VS 2023 VS 2030
1.3 Global Laboratory-developed Testing Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 LABORATORY-DEVELOPED TESTING MARKET DYNAMICS
2.1 Laboratory-developed Testing Industry Trends
2.2 Laboratory-developed Testing Industry Drivers
2.3 Laboratory-developed Testing Industry Opportunities and Challenges
2.4 Laboratory-developed Testing Industry Restraints
3 LABORATORY-DEVELOPED TESTING MARKET BY COMPANY
3.1 Global Laboratory-developed Testing Company Revenue Ranking in 2023
3.2 Global Laboratory-developed Testing Revenue by Company (2019-2024)
3.3 Global Laboratory-developed Testing Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Laboratory-developed Testing Company Manufacturing Base & Headquarters
3.5 Global Laboratory-developed Testing Company, Product Type & Application
3.6 Global Laboratory-developed Testing Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Laboratory-developed Testing Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Laboratory-developed Testing Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 LABORATORY-DEVELOPED TESTING MARKET BY TYPE
4.1 Laboratory-developed Testing Type Introduction
4.1.1 Commercial Service
4.1.2 R&D
4.2 Global Laboratory-developed Testing Sales Value by Type
4.2.1 Global Laboratory-developed Testing Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Laboratory-developed Testing Sales Value by Type (2019-2030)
4.2.3 Global Laboratory-developed Testing Sales Value Share by Type (2019-2030)
5 LABORATORY-DEVELOPED TESTING MARKET BY APPLICATION
5.1 Laboratory-developed Testing Application Introduction
5.1.1 Genetic Testing
5.1.2 Oncology
5.1.3 Infectious Disease
5.1.4 Others
5.2 Global Laboratory-developed Testing Sales Value by Application
5.2.1 Global Laboratory-developed Testing Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Laboratory-developed Testing Sales Value by Application (2019-2030)
5.2.3 Global Laboratory-developed Testing Sales Value Share by Application (2019-2030)
6 LABORATORY-DEVELOPED TESTING MARKET BY REGION
6.1 Global Laboratory-developed Testing Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Laboratory-developed Testing Sales Value by Region (2019-2030)
6.2.1 Global Laboratory-developed Testing Sales Value by Region: 2019-2024
6.2.2 Global Laboratory-developed Testing Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Laboratory-developed Testing Sales Value (2019-2030)
6.3.2 North America Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Laboratory-developed Testing Sales Value (2019-2030)
6.4.2 Europe Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Laboratory-developed Testing Sales Value (2019-2030)
6.5.2 Asia-Pacific Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Laboratory-developed Testing Sales Value (2019-2030)
6.6.2 Latin America Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Laboratory-developed Testing Sales Value (2019-2030)
6.7.2 Middle East & Africa Laboratory-developed Testing Sales Value Share by Country, 2023 VS 2030
7 LABORATORY-DEVELOPED TESTING MARKET BY COUNTRY
7.1 Global Laboratory-developed Testing Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Laboratory-developed Testing Sales Value by Country (2019-2030)
7.2.1 Global Laboratory-developed Testing Sales Value by Country (2019-2024)
7.2.2 Global Laboratory-developed Testing Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.3.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.4.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.5.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.6.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.7.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.8.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.9.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.10.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.11.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.12.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.13.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.14.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.15.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.16.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.17.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.18.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.19.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.20.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Laboratory-developed Testing Sales Value Growth Rate (2019-2030)
7.21.2 Global Laboratory-developed Testing Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Laboratory-developed Testing Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Adaptive Biotechnologies Corporation
8.1.1 Adaptive Biotechnologies Corporation Comapny Information
8.1.2 Adaptive Biotechnologies Corporation Business Overview
8.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio
8.1.5 Adaptive Biotechnologies Corporation Recent Developments
8.2 Quest Diagnostics
8.2.1 Quest Diagnostics Comapny Information
8.2.2 Quest Diagnostics Business Overview
8.2.3 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.2.4 Quest Diagnostics Laboratory-developed Testing Product Portfolio
8.2.5 Quest Diagnostics Recent Developments
8.3 Roche
8.3.1 Roche Comapny Information
8.3.2 Roche Business Overview
8.3.3 Roche Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.3.4 Roche Laboratory-developed Testing Product Portfolio
8.3.5 Roche Recent Developments
8.4 Illumina
8.4.1 Illumina Comapny Information
8.4.2 Illumina Business Overview
8.4.3 Illumina Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.4.4 Illumina Laboratory-developed Testing Product Portfolio
8.4.5 Illumina Recent Developments
8.5 Qiagen
8.5.1 Qiagen Comapny Information
8.5.2 Qiagen Business Overview
8.5.3 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.5.4 Qiagen Laboratory-developed Testing Product Portfolio
8.5.5 Qiagen Recent Developments
8.6 Eurofins
8.6.1 Eurofins Comapny Information
8.6.2 Eurofins Business Overview
8.6.3 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.6.4 Eurofins Laboratory-developed Testing Product Portfolio
8.6.5 Eurofins Recent Developments
8.7 Guardant Health
8.7.1 Guardant Health Comapny Information
8.7.2 Guardant Health Business Overview
8.7.3 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.7.4 Guardant Health Laboratory-developed Testing Product Portfolio
8.7.5 Guardant Health Recent Developments
8.8 Biotheranostics
8.8.1 Biotheranostics Comapny Information
8.8.2 Biotheranostics Business Overview
8.8.3 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.8.4 Biotheranostics Laboratory-developed Testing Product Portfolio
8.8.5 Biotheranostics Recent Developments
8.9 Adaptive Biotechnologies
8.9.1 Adaptive Biotechnologies Comapny Information
8.9.2 Adaptive Biotechnologies Business Overview
8.9.3 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.9.4 Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio
8.9.5 Adaptive Biotechnologies Recent Developments
8.10 Rosetta Genomics
8.10.1 Rosetta Genomics Comapny Information
8.10.2 Rosetta Genomics Business Overview
8.10.3 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.10.4 Rosetta Genomics Laboratory-developed Testing Product Portfolio
8.10.5 Rosetta Genomics Recent Developments
8.11 Biodesix
8.11.1 Biodesix Comapny Information
8.11.2 Biodesix Business Overview
8.11.3 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.11.4 Biodesix Laboratory-developed Testing Product Portfolio
8.11.5 Biodesix Recent Developments
8.12 Helix
8.12.1 Helix Comapny Information
8.12.2 Helix Business Overview
8.12.3 Helix Laboratory-developed Testing Revenue and Gross Margin (2019-2024)
8.12.4 Helix Laboratory-developed Testing Product Portfolio
8.12.5 Helix Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
10.6 Disclaimer
